Search research articles
Contact Us
Filters
Showing results (11-20 of 137) with videos related to
Page
of 14
Sort By:
International Journal of Dermatology
|
July 2, 2021
Could it be gluten? Additional skin conditions associated with celiac disease
Natasha Klemm, Melinda J Gooderham, Kim Papp
The Journal of Clinical and Aesthetic Dermatology
|
April 26, 2017
Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR
April W Armstrong, Kim Papp, Leon Kircik
Acta Dermato-Venereologica
|
February 8, 2024
Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis
Ahmad Jalili, Henrik Thoning, Marie Y Jablonski Bernasconi, et al.
Journal of Cutaneous Medicine and Surgery
|
September 27, 2013
Preparing for subsequent entry biologics in dermatology and rheumatology in Canada
Kim Papp, Marc Bourcier, Vincent Ho, et al.
Expert Opinion on Investigational Drugs
|
August 4, 2020
Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
Novin Nezamololama, Erika L Crowley, Melinda J Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
July 26, 2011
Canadian guidelines for the management of plaque psoriasis: overview
Kim Papp, Wayne Gulliver, Charles Lynde, et al.
Expert Review of Clinical Immunology
|
September 24, 2020
Abrocitinib for the treatment of atopic dermatitis
Erika L Crowley, Novin Nezamololama, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
July 21, 2010
Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed population
Kim Papp, Fernando Valenzuela, Yves Poulin, et al.
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey
Melinda Gooderham, Kim Papp, Lorne Albrecht, et al.
International Journal of Dermatology
|
August 23, 2021
Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis
Hannah Wood, Antoinette Chandler, Novin Nezamololama, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 137) with videos related to
Sort By:
Page
of 14
International Journal of Dermatology
|
July 2, 2021
Could it be gluten? Additional skin conditions associated with celiac disease
Natasha Klemm, Melinda J Gooderham, Kim Papp
The Journal of Clinical and Aesthetic Dermatology
|
April 26, 2017
Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR
April W Armstrong, Kim Papp, Leon Kircik
Acta Dermato-Venereologica
|
February 8, 2024
Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis
Ahmad Jalili, Henrik Thoning, Marie Y Jablonski Bernasconi, et al.
Journal of Cutaneous Medicine and Surgery
|
September 27, 2013
Preparing for subsequent entry biologics in dermatology and rheumatology in Canada
Kim Papp, Marc Bourcier, Vincent Ho, et al.
Expert Opinion on Investigational Drugs
|
August 4, 2020
Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
Novin Nezamololama, Erika L Crowley, Melinda J Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
July 26, 2011
Canadian guidelines for the management of plaque psoriasis: overview
Kim Papp, Wayne Gulliver, Charles Lynde, et al.
Expert Review of Clinical Immunology
|
September 24, 2020
Abrocitinib for the treatment of atopic dermatitis
Erika L Crowley, Novin Nezamololama, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
July 21, 2010
Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed population
Kim Papp, Fernando Valenzuela, Yves Poulin, et al.
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey
Melinda Gooderham, Kim Papp, Lorne Albrecht, et al.
International Journal of Dermatology
|
August 23, 2021
Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis
Hannah Wood, Antoinette Chandler, Novin Nezamololama, et al.
Page
of 14